Analysis of the prognostic factors determining the oncological outcomes in patients with high-risk early-stage cervical cancer

References

• Bhatla N, Berek J, Cuello M, Denny L, Grenman S, Karunaratne K. 2018. New revised FIGO staging of cervical cancer (2018). Abstract S020. 2. FIGO XXII World Congress of Gynecology and Obstetrics. Rio de Janeiro, Brazil. 22-36.
   Google Scholar
• Biewenga P, van der Velden J, Mol BW, Stalpers LJ, Schilthuis MS, van der Steeg JW, et al. 2009. Validation of existing prognostic models in patients with early-stage cervical cancer. Gynecologic Oncology 115:277–284.
   PubMed Web of Science ®Google Scholar
• Boussios S, Seraj E, Zarkavelis G, Petrakis D, Kollas A, Kafantari A, et al. 2016. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review. Critical Reviews in Oncology/Hematology 108:164–174.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68:394–424.
   PubMed Web of Science ®Google Scholar
• Carcangiu M, Kurman RJ, Carcangiu ML, Herrington CS. 2014. WHO classification of tumours of female reproductive organs. International Agency for Research on Cancer.
   Google Scholar
• Cohen PA, Jhingran A, Oaknin A, Denny L. 2019. Cervical cancer. Lancet (London, England) 393:169–182.
   PubMed Web of Science ®Google Scholar
• Creasman W. 1989. Announcement FIGO stages: 1988 revisions. Gynecologic Oncology 35:125–127.
   Google Scholar
• Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. 1990. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecologic Oncology 38:352–357.
   PubMed Web of Science ®Google Scholar
• Fedewa SA, Cokkinides V, Virgo KS, Bandi P, Saslow D, Ward EM. 2012. Association of insurance status and age with cervical cancer stage at diagnosis: National Cancer Database, 2000-2007. American Journal of Public Health 102:1782–1790.
   PubMed Web of Science ®Google Scholar
• Kim SW, Chun M, Ryu HS, Chang SJ, Kong TW, Oh YT, et al. 2017. Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy. BMC Cancer 17:297.
   PubMed Web of Science ®Google Scholar
• Kim H, Park W, Kim YS, Kim YJ. 2020. Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor. Journal of Gynecologic Oncology 31:e35.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Rhee WJ, Choi SH, Nam EJ, Kim SW, Kim S, et al. 2015. Clinical outcomes of adjuvant radiation therapy and prognostic factors in early stage uterine cervical cancer. Radiation Oncology Journal 33:126–133.
   PubMed Web of Science ®Google Scholar
• La Rosa VL, Garzon S, Gullo G, Fichera M, Sisti G, Gallo P, et al. 2020. Fertility preservation in women affected by gynaecological cancer: The importance of an integrated gynaecological and psychological approach. Ecancermedicalscience 14:1035.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Nusbaum DJ, Machida H, Huang Y, Khetan V, Matsuzaki S, et al. 2020. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone. American Journal of Obstetrics and Gynecology 222:484.e481–484.e415.
   Web of Science ®Google Scholar
• Matsuo K, Shimada M, Aoki Y, Sakamoto M, Takeshima N, Fujiwara H, et al. 2017. Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation. International Journal of Cancer 141:1042–1051.
   PubMed Web of Science ®Google Scholar
• Peters WA, 3rd, Liu PY, Barrett RJ, 2nd, Stock RJ, Monk BJ, Berek JS, et al. 2000. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Journal of Clinical Oncology 18:1606–1613.
   PubMed Web of Science ®Google Scholar
• Piura B, Rabinovich A, Friger M. 2008. Recurrent cervical carcinoma after radical hysterectomy and pelvic lymph node dissection: A study of 32 cases. European Journal of Gynaecological Oncology 29:31–36.
   PubMed Web of Science ®Google Scholar
• Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. 2006. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 95 Suppl 1:S43–S103.
   Web of Science ®Google Scholar
• Radiation Therapy Oncology Group. 2019. Chemotherapy and pelvic radiation therapy with or without additional chemotherapy in treating patients with high-risk early-stage cervical cancer after radical hysterectomy. Available from: https://clinicaltrials.gov/ct2/show/NCT00980954#contacts [Accessed 1 September 2020].
   Google Scholar
• Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. 1999. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecologic Oncology 73:177–183.
   PubMed Web of Science ®Google Scholar
• Sehouli J, Runnebaum IB, Fotopoulou C, Blohmer U, Belau A, Leber H, et al. 2012. A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study. Annals of Oncology 23:2259–2264.
   PubMed Web of Science ®Google Scholar
• Takekuma M, Kasamatsu Y, Kado N, Kuji S, Tanaka A, Takahashi N, et al. 2017. The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review. The Journal of Obstetrics and Gynaecology Research 43:617–626.
   PubMed Web of Science ®Google Scholar
• Trifiletti DM, Swisher-McClure S, Showalter TN, Hegarty SE, Grover S. 2015. Postoperative chemoradiation therapy in high-risk cervical cancer: re-evaluating the findings of gynecologic oncology group study 109 in a large, population-based cohort. International Journal of Radiation Oncology*Biology*Physics 93:1032–1044.
   Web of Science ®Google Scholar
• Wright JD, Matsuo K, Huang Y, Tergas AI, Hou JY, Khoury-Collado F, et al. 2019. Prognostic performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines. Obstetrics and Gynecology 134:49–57.
   PubMed Web of Science ®Google Scholar